Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular CarcinomaMin Yu, Zonghai Li, Hong Luo et al.|Molecular Therapy|2017Cited by 184
Incidence and outcomes of acute respiratory distress syndrome in intensive care units of mainland China: a multicentre prospective longitudinal studyXu Huang, Xia Luo, Ruoyang Zhang et al.|Critical Care|2020Cited by 107
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion proteinZeyan Pan, Zonghai Li, Zhimin Shi et al.|Cancer Immunology Immunotherapy|2018Cited by 63
Spectrum and Clinical Characteristics of Symptomatic and Asymptomatic Coronavirus Disease 2019 (COVID-19) With and Without PneumoniaHuihui Zeng, Yan Chen, Yiming Ma et al.|Frontiers in Medicine|2021Cited by 63
Regulation of Runx2 by microRNA-9 and microRNA-10 modulates the osteogenic differentiation of mesenchymal stem cellsHong Luo, Bing Qiu|International Journal of Molecular Medicine|2017Cited by 32